Back to VRTX Stock Lookup

Vertex Pharma (VRTX) – Company Press Releases

Jul 31, 2014 04:18 PM Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations
Jul 29, 2014 04:01 PM Vertex Reports Second Quarter 2014 Financial Results and Provides Updates on Key Research and Development Programs
Jul 14, 2014 04:01 PM Vertex to Announce Second Quarter 2014 Financial Results on July 29
Jul 10, 2014 08:00 AM Vertex Announces Retirement of Peter Mueller, Ph.D.
Jun 30, 2014 04:05 PM Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO® (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation
Jun 27, 2014 07:14 AM Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations
Jun 24, 2014 07:00 AM Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis who have
Jun 18, 2014 08:30 AM Vertex Licenses VX-787 to Janssen Pharmaceuticals for the Treatment of Influenza
Jun 16, 2014 05:15 PM Vertex Announces a Signed Letter of Intent to Enable Public Reimbursement of KALYDECO® (ivacaftor) in Canada for Eligible People with Cystic Fibrosis
Jun 12, 2014 12:12 PM Kirby McInerney LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals, Inc.
Jun 12, 2014 12:12 PM Kirby McInerney LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals, Inc.
Jun 12, 2014 09:00 AM Vertex Announces Presentation of New KALYDECO™ (ivacaftor) Data at European Cystic Fibrosis Society Conference
Jun 4, 2014 08:00 AM Proof-of-Concept Study of Ivacaftor Monotherapy Showed Improvements in Lung Function After Two Weeks of Treatment in People with Cystic Fibrosis who have a Residual Function Mutation
Jun 3, 2014 04:01 PM Vertex to Present at the Goldman Sachs Global Healthcare Conference on June 10

Back to VRTX Stock Lookup